VIR-165, a modified form of virus inhibitory peptide (VIRIP), corresponds to residues 353 to 372 in the C-proximal region of human alpha1-antitrypsin, the most abundant circulating serine protease inhibitor. VIRIP inhibits a wide variety of human immune responses.